{'52WeekChange': -0.35842294,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Building 1',
 'address2': 'Suite 300 1120 South Capital of Texas Highway',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.08,
 'askSize': 1800,
 'averageDailyVolume10Day': 61862,
 'averageVolume': 31009,
 'averageVolume10days': 61862,
 'beta': 1.214745,
 'beta3Year': None,
 'bid': 1.78,
 'bidSize': 1100,
 'bookValue': -0.258,
 'category': None,
 'circulatingSupply': None,
 'city': 'Austin',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.95,
 'dayLow': 1.78,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -2.932,
 'enterpriseToRevenue': 1.443,
 'enterpriseValue': 69577304,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '512 279 5105',
 'fiftyDayAverage': 1.668,
 'fiftyTwoWeekHigh': 3.79,
 'fiftyTwoWeekLow': 1.24,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 10554332,
 'forwardEps': -0.97,
 'forwardPE': -1.8453608,
 'fromCurrency': None,
 'fullTimeEmployees': 217,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.13971,
 'heldPercentInstitutions': 0.66055,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1483056000,
 'lastSplitFactor': '10:55',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/apolloendo.com',
 'longBusinessSummary': 'Apollo Endosurgery, Inc., a medical technology '
                        'company, focuses on the design, development, and '
                        'commercialization of medical devices. The company '
                        'offers OverStitch and OverStitch Sx Endoscopic '
                        'Suturing Systems that enable advanced endoscopic '
                        'procedures by allowing physicians to place full '
                        'thickness sutures and secure the approximation of '
                        'tissue through a flexible endoscope. It also provides '
                        'Orbera, an intragastric balloon system that reduces '
                        'stomach capacity causing patients to consume less '
                        'following the procedure, and delays gastric content '
                        'emptying under the Orbera Intragastric Balloon '
                        'System, BIB, and Orbera365 Managed Weight Loss System '
                        'brands; and Orbera Coach, a digital and remotely '
                        'delivered aftercare program. The company sells its '
                        'products to medical services providers; and '
                        'hospitals, outpatient surgical centers, clinics, and '
                        'physicians in the United States, Brazil, Australia, '
                        'and other European countries. Apollo Endosurgery, '
                        'Inc. was founded in 2005 and is headquartered in '
                        'Austin, Texas.',
 'longName': 'Apollo Endosurgery, Inc.',
 'market': 'us_market',
 'marketCap': 42380756,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_37790054',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -34884000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.9,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '512 279 5100',
 'previousClose': 1.88,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 0.8789041,
 'profitMargins': -0.72343004,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.95,
 'regularMarketDayLow': 1.78,
 'regularMarketOpen': 1.9,
 'regularMarketPreviousClose': 1.88,
 'regularMarketPrice': 1.9,
 'regularMarketVolume': 82981,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 23676400,
 'sharesPercentSharesOut': 0.0176,
 'sharesShort': 373994,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 390023,
 'shortName': 'Apollo Endosurgery, Inc.',
 'shortPercentOfFloat': 0.025,
 'shortRatio': 8.9,
 'startDate': None,
 'state': 'TX',
 'strikePrice': None,
 'symbol': 'APEN',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.634,
 'twoHundredDayAverage': 2.2009354,
 'volume': 82981,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.apolloendo.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '78746'}